Tom Defay

Company: Alexion, AstraZeneca Rare Disease

Job title: Deputy Head Diagnostics Strategy and Development

Seminars:

Enhancing Rare Disease Diagnosis Through Genome Sequencing and Genetics 3:15 pm

• Advances in widescale characterization of variants of uncertain significance • Impact of whole genome sequencing on rare disease diagnosis • Impact across a set of Rare DiseasesRead more

day: Day Two